CannabisNewsBreaks – Cannabis Global Inc. (CBGL) Announces Filing of Patent for New Class of ‘Revolutionary’ Nano Cannabinoid

November 4, 2020 12:16:25

Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing unique infusion technologies and products, has filed a new patent application. The nonprovisional application is a direct result of CBGL’s Project Varin and expands on the technologies and developments contained in the company’s provisional applications filed on Nov. 4, 2019. This recent application outlines new methods for the manufacture of highly bioavailable and ultra-fast-acting cannabinoids for use in a variety of applications, including in beverages, food and topicals. Calling the technology “revolutionary,” the announcement notes that this patent may rewrite the efficacy and cost equations in the cannabis industry; the technology also provides for considerably faster onset of active cannabinoids ingredients, with the potential to reduce the time from hours to minutes. “We believe what we have created is highly significant to the cannabis industry, especially as nationwide cannabis legalization looms on the horizon,” Cannabis Global CEO Arman Tabatabaei said in the press release. “This new cannabinoid delivery system is designed to allow beverage, food and cosmetic product formulators to use significantly less cannabinoids in products while achieving similar or meaningfully greater efficacy. Our patent filing covers not only the new processes developed to create the new forms of cannabinoids but also the nanoparticles and nanofibers using the outlined processes and ingredients. We are especially proud of the fact we have been able to use food-grade ingredients in many of the formulations allowing consumer product companies to produce the clean labels consumers are increasingly desiring.”

To view the full press release, visit

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit

NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.